Aytu BioScience
Margaret Cabano has served as the Vice President of Operations for Aytu BioPharma since the merger of Aytu BioScience and Neos Therapeutics in 2021. Ms. Cabano held the same role for Neos Therapeutics since 2005. She has 21 years of industry experience and leads all aspects of manufacturing operations, including supply chain, engineering, and technical services. Prior to joining Neos, Ms. Cabano worked in operations and supply chain management for Adams Respiratory Therapeutics and Cardinal Health. Ms. Cabano holds an M.B.A. in Operations Management Science and a B.A. in Supply Chain Logistics from the University of North Texas.
This person is not in any offices
Aytu BioScience
2 followers
Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.